Back to Trials
NCT07282691RecruitingAccepts Healthy Volunteers

Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders

Salus University

Start Date

4/1/2025

Completion Date

9/29/2028

Summary

The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.

Detailed Description

Participants with (n=50) and without (n=100) a history of mTBI will be recruited. Investigators will study the use of a series of visual endurance tests (tests that require sustained visual responses over a period of time). In addition to developing expected values for these tests, investigators will also after qualitative data about discomfort levels during testing.

Eligibility Criteria

Age Range: 18 years to 35 years

Inclusion Criteria: * Diagnosis of mTBI within previous 1 to 6 months * Distance visual acuity better than or equal to 20/25 in each eye * Score \>21 on Convergence Insufficiency Symptom Survey Exclusion Criteria: * Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness * Not wearing required refractive error) * Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination) * Cognitive delays that may impact testing

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

MTBI - Mild Traumatic Brain Injury

Locations

The Eye Institute

Philadelphia, Pennsylvania 19141

United States